Adenosine Influences Foxp3 Expression of Tregs via the A2ar/Creb Pathway in a Mouse Model of Sepsis

Abstract

The adenosine concentration and forkhead box protein (Foxp3) expression in T regulatory cells (Tregs) are increased during sepsis. However, the mechanism by which adenosine induces Foxp3 expression is incompletely understood. A cecal ligation and puncture (CLP) model was constructed using C57BL/J mice. The plasma adenosine concentration and Foxp3 expression in splenic Tregs were increased consistently for 15 days after sepsis onset. Analysis of the mean fluorescence intensity of Foxp3 and adenosine concentration in the same mice revealed a linear correlation. In the CLP model, adenosine 2a receptor (A2aR) blockade inhibited Foxp3 expression in Tregs. In vitro activation of A2aR promoted Foxp3 expression in Tregs and facilitated secretion of extracellular vesicles. Transcriptome sequencing revealed that A2aR blockade led to changes in cyclic adenosine monophosphate response element-binding protein (CREB) transcription in Tregs in our sepsis model. Use of adenosine or A2aR agonists promoted CREB expression, CREB phosphorylation at S133, Treg expression of Foxp3, and enhanced inhibition of proliferation of cluster of differentiation (CD)4+ lymphocytes. A2aR blockade or inhibition of CREB expression inhibited Foxp3 expression in Tregs. In the CLP model, use of CREB inhibitors could inhibit Foxp3 expression and reduce the bacterial load. In summary, adenosine in sepsis promotes CREB phosphorylation via A2aR which, in turn, upregulates Foxp3 expression in Tregs.

Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: progress in basic research and clinical application

“…The ADO produced in the TME binds to A2 receptors (A2R) on monocytes ( 16 ), dendritic cells (DCs) ( 17 ), myeloid-derived suppressor cells (MDSCs) ( 18 ), regulatory T cells (Tregs) ( 19 , 20 ), and macrophages ( 21 , 22 ), thereby modulating their differentiation and function ( 16 , 18 – 20 , 23 – 26 ), ultimately leading to the induction of an immunosuppressive microenvironment conducive to lung cancer development ( 27 , 28 ). Various inhibitors targeting the ADO pathway can improve the immunosuppressive microenvironment by inhibiting the process by which ADO acts, or by directly inhibiting ADO production ( 14 ).…”